Consistency of histopathological reporting of breast lesions detected by screening: findings of the U.K. National External Quality Assessment (EQA) Scheme. U. K. National Coordinating Group for Breast Screening Pathology.
about
Molecular genetics of solid tumours: translating research into clinical practice. What we could do now: breast cancerThe pathology of familial breast cancer: Morphological aspects.The diagnosis and management of pre-invasive breast disease: genetic alterations in pre-invasive lesionsDCIS grading schemes and clinical implications.Consistency in the observation of features used to classify duct carcinoma in situ (DCIS) of the breastMeasures of benefit for breast screening from the pathology database for Scotland, 1991-2001Impact of a national external quality assessment scheme for breast pathology in the UKPrecursors and preinvasive lesions of the breast: the role of molecular prognostic markers in the diagnostic and therapeutic dilemma.Understanding diagnostic variability in breast pathology: lessons learned from an expert consensus review panel.Epithelial displacement during breast needle core biopsy causes diagnostic difficulties in subsequent surgical excision specimensImpact of preventive therapy on the risk of breast cancer among women with benign breast disease.Maximising benefit and minimising harm of screening.Benign breast disease, mammographic breast density, and the risk of breast cancer.Reproducibility of new classification schemes for the pathology of ductal carcinoma in situ of the breast.Assessing diagnostic errors: when is suspension of a pathologist justified?Atypical ductal hyperplasia of the breast: clonal proliferation with loss of heterozygosity on chromosomes 16q and 17p.Review of the national external quality assessment (EQA) scheme for breast pathology in the UK.Risk Factors That Increase Risk of Estrogen Receptor-Positive and -Negative Breast Cancer.Rural-urban differences in radiation therapy for ductal carcinoma in-situ of the breast.Evaluation of the use of digital images for a national prostate core external quality assurance scheme.Ductal carcinoma in situ (DCIS) of the breast: the need for psychosocial research.Ductal epithelial proliferations of the breast: a biological continuum? Comparative genomic hybridization and high-molecular-weight cytokeratin expression patterns.Breast cancer prognostication in the 21st century and the Nottingham prognostic index.Application of the van nuys prognostic index in a retrospective series of 367 ductal carcinomas in situ of the breast examined by serial macroscopic sectioning: practical considerations.Impact of immunohistochemical markers, CK5/6 and E-cadherin on diagnostic agreement in non-invasive proliferative breast lesions.Histological features associated with diagnostic agreement in atypical ductal hyperplasia of the breast: illustrative cases from the B-Path study.Tumour size as a predictor of axillary node metastases in patients with breast cancer.Measurement of whole tumour size in breast cancer specimens.Inter-observer variation between general and specialist gastrointestinal pathologists when grading dysplasia in ulcerative colitis.Label-free quantitative evaluation of breast tissue using Spatial Light Interference Microscopy (SLIM).Detection method and breast carcinoma histology
P2860
Q24535378-C815418D-9A41-479A-B03E-FCA5C5F358E0Q24800393-59680A43-1A3E-4980-AC4A-7070576C51A4Q24802857-32D076DA-AF9F-46AD-BAA6-A5B312A6F14AQ33785753-0F444FDA-053E-4E38-BC87-8666CFF8745EQ35571004-DBD015FE-7B59-4C8B-A226-E4AC6431244EQ35587020-4BEB8F56-5D7A-4AAF-AA38-5E6F4AEEA4DAQ35769734-CCD884A6-E2D4-447F-BA7C-5C4B12D83E99Q35846896-0EA72F73-9DE0-4476-92A2-8DCDA5838F5CQ35862396-70D313E5-C6CB-43BB-A7E3-F0DFD5AF2C6FQ36026103-A7DEAE20-6421-44F4-A27D-1DE113AA9025Q36258270-AE907C05-A368-458B-A0EB-8315516F7954Q36482925-8E75C266-73BA-4F52-B1E9-33C747745B37Q37021220-54DA9CF5-46F4-4966-9888-6C40C3D811E3Q37223363-033D0EB2-87C2-439C-909F-27F656D580B1Q37227146-8F0E474C-8C60-485E-9499-31620871C1F0Q37263268-8DD0C07F-6B48-408B-8980-6EB9A2443831Q38894293-AE7A21C4-9331-4260-88EB-9946F0B4925EQ39045823-0FAD5802-E602-4C6D-A164-5CA2BE3D76AFQ39584733-97A1B952-C19F-4407-BF9D-85415A2429B6Q40003674-81458C4C-332D-484C-97EF-9D4BFCF6BE2FQ40785431-8F4E14F5-41AA-42BA-AAE7-1326C7CF7E45Q42514277-13361464-05EC-4E17-9F21-AC94A8C80CE6Q43011646-C332F1C1-9B4F-442A-AC39-49387863E99DQ44584714-6665D50C-DC3D-405B-88FF-1F0201259636Q46657505-00E9EB4A-999E-45D8-9AE3-8CB982299766Q47117094-20EE7023-4C3B-4CB3-B917-C05C2AE651F7Q47316750-DFEC9A5A-374F-46ED-8A46-9446B487B4C0Q47364105-45CD82FD-9F16-41C1-9DDB-4713E2FA28E8Q52932163-D79C4B92-2252-44EA-8702-20F56E8F0F01Q54964088-E70C7196-E889-4D16-974D-9F5B67C150E4Q57268423-A0C4C229-4524-4120-B790-02F71B410797
P2860
Consistency of histopathological reporting of breast lesions detected by screening: findings of the U.K. National External Quality Assessment (EQA) Scheme. U. K. National Coordinating Group for Breast Screening Pathology.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh
1994年學術文章
@zh-hant
name
Consistency of histopathologic ...... or Breast Screening Pathology.
@en
type
label
Consistency of histopathologic ...... or Breast Screening Pathology.
@en
prefLabel
Consistency of histopathologic ...... or Breast Screening Pathology.
@en
P2093
P1476
Consistency of histopathologic ...... for Breast Screening Pathology
@en
P2093
C W Elston
J D Davies
J P Sloane
N S Dallimore
T J Anderson
P304
P356
10.1016/0959-8049(94)00261-3
P50
P577
1994-01-01T00:00:00Z